Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,411,934
  • Shares Outstanding, K 76,448
  • Annual Sales, $ 361,050 K
  • Annual Income, $ -74,400 K
  • 60-Month Beta 1.65
  • Price/Sales 6.80
  • Price/Cash Flow 344.13
  • Price/Book 2.16
Trade VCYT with:

Options Overview Details

View History
  • Implied Volatility 69.37% ( -8.36%)
  • Historical Volatility 80.91%
  • IV Percentile 23%
  • IV Rank 57.08%
  • IV High 109.07% on 04/15/24
  • IV Low 16.55% on 05/29/24
  • Put/Call Vol Ratio 0.50
  • Today's Volume 3
  • Volume Avg (30-Day) 132
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 1,454
  • Open Int (30-Day) 1,298

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.02
  • Number of Estimates 3
  • High Estimate 0.06
  • Low Estimate -0.06
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +166.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.73 +59.91%
on 08/05/24
33.33 -5.34%
on 08/16/24
+7.98 (+33.86%)
since 07/30/24
3-Month
19.73 +59.91%
on 08/05/24
33.33 -5.34%
on 08/16/24
+10.56 (+50.31%)
since 05/30/24
52-Week
18.61 +69.53%
on 04/18/24
33.33 -5.34%
on 08/16/24
+5.25 (+19.96%)
since 08/29/23

Most Recent Stories

More News
Veracyte: Q2 Earnings Snapshot

Veracyte: Q2 Earnings Snapshot

VCYT : 31.55 (-1.22%)
Veracyte: Q1 Earnings Snapshot

Veracyte: Q1 Earnings Snapshot

VCYT : 31.55 (-1.22%)
Veracyte: Q4 Earnings Snapshot

Veracyte: Q4 Earnings Snapshot

VCYT : 31.55 (-1.22%)
Veracyte: Q3 Earnings Snapshot

Veracyte: Q3 Earnings Snapshot

VCYT : 31.55 (-1.22%)
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?

The genetic test maker is rapidly increasing test volumes.

AZN : 87.62 (+0.37%)
COMP : 5.13 (-0.77%)
VCYT : 31.55 (-1.22%)
Veracyte: Q2 Earnings Snapshot

Veracyte: Q2 Earnings Snapshot

VCYT : 31.55 (-1.22%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

/PRNewswire/ -- USA News Group - With this year's Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there's...

ONC.TO : 1.28 (unch)
ONCY : 0.9590 (+0.66%)
JAZZ : 115.98 (+0.33%)
GERN : 4.75 (+4.17%)
INAB : 0.5264 (+1.39%)
VCYT : 31.55 (-1.22%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END

ONCY : 0.9590 (+0.66%)
ONC.TO : 1.28 (unch)
JAZZ : 115.98 (+0.33%)
GERN : 4.75 (+4.17%)
INAB : 0.5264 (+1.39%)
VCYT : 31.55 (-1.22%)
Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023

USA News Group – With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there’s plenty of anticipation for updates on some of the biggest...

ONCY : 0.9590 (+0.66%)
ONC.TO : 1.28 (unch)
JAZZ : 115.98 (+0.33%)
GERN : 4.75 (+4.17%)
INAB : 0.5264 (+1.39%)
VCYT : 31.55 (-1.22%)
Here's Why This Little-Known Growth Stock Is a Buy

Analysts think this genomic test maker could have major upside in the next year.

VCYT : 31.55 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also...

See More

Key Turning Points

3rd Resistance Point 32.94
2nd Resistance Point 32.52
1st Resistance Point 32.04
Last Price 31.55
1st Support Level 31.13
2nd Support Level 30.71
3rd Support Level 30.23

See More

52-Week High 33.33
Last Price 31.55
Fibonacci 61.8% 27.71
Fibonacci 50% 25.97
Fibonacci 38.2% 24.23
52-Week Low 18.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar